Go Back to Corporate

Practice

Capital Markets

We leverage our broad experience and deep industry knowledge to help clients navigate global markets and achieve their capital-raising objectives. We focus on minimizing regulatory and economic risks while positioning our clients for potential opportunities. Our team represents domestic and foreign issuers, underwriters, selling and controlling shareholders, and other market participants in a wide range of capital markets transactions.

We serve clients across diverse industries, including energy, financial services, health care, life sciences, insurance and reinsurance, real estate, technology, telecommunications, advertising, and more. Our comprehensive, global counsel covers all phases of capital market deals, from corporate structuring and governance to regulatory compliance and deal execution.

Our services include:

Read More

2025 SEC Filing Deadlines and Financial Statements Staleness Dates

For companies with a fiscal year ending December 31, 2024

Access the calendar

  • Bloomberg – Global Legal Adviser League Tables – Global Equity, Equity Linked & Rights – Issuer Ranked by Volume – #19 Ranked Firm (Full Year 2024)
  • Bloomberg – Global Legal Adviser League Tables – U.S. Equity Linked: Legal Adviser – Issuer Ranked by Volume – #4 Ranked Firm (Full Year 2024)
  • Bloomberg – Global Legal Adviser League Tables – U.S. Equity Linked: Legal Adviser – Issuer Ranked by Deal Count – #5 Ranked Firm (Full Year 2024)
  • LSEG (formerly Refinitiv) – Global Capital Markets Legal Review – Canada Equity & Equity-Related (# of Deals) – #9 Ranked Firm (Full Year 2024)

Client Success Stories

Troutman Pepper Locke Represents Unisys Corporation in Connection With Private Placement of $700 Million Senior Secured Notes, Related Cash Tender Offer, Consent Solicitation for Currently Outstanding Senior Secured Notes, and Amendments to Asset-Based Lending Facility

Read More

How we helped

Our highest goal? Achieving yours.

Exceptional results are our best practice

Find your professional

This just in

See all insights

Speaking Engagements

2025 Public Company Seminar

October 29, 2025  |  12:00 PM – 2:30 PM ET
Virtual Webinar

Blog Post

Texas Stock Exchange Announces Approval by SEC 

October 1, 2025

Articles + Publications

Texas Stock Exchange Announces Approval by SEC 

October 1, 2025

Firm News

Troutman Pepper Locke Advises Eupraxia Pharmaceuticals on $80 Million Public Offering of Common Shares

September 26, 2025

See all insights